Home Healthcare Market Size, Share, and Trends

Home Healthcare Market Size, Share & Growth Analysis Report By Equipment Type (Therapeutic, Diagnostic), By Service (Skilled Home Healthcare Services, Unskilled Home Healthcare Services) - Global Industry Analysis, Trends, Segment Forecasts, Regional Outlook 2024 - 2033

  • Last Updated : April 2024
  • Report Code : 1190
  • Category : Healthcare

The global home healthcare market size was valued at USD 373.56 billion in 2023 and is expected to reach around USD 1,469.92 billion by 2033 and is poised to grow at a CAGR of 14.81% during the forecast period from 2024 to 2033.

Home Healthcare Market Size 2024 to 2033

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Home Healthcare Market Key Takeaways

  • North America led the global market with the highest market share of 50.59% in 2023.
  • By type, the services segment registered a maximum market share of 84.07% in 2023.
  • By device, the home mobility assist devices segment captured the biggest revenue share of 40.26% in 2023.
  • By service, the rehabilitation segment has held the largest market share of 44.12% in 2023.

Home Healthcare Market Size in the U.S. 2024 to 2033

The U.S. home healthcare market size reached USD 171.95 billion in 2023 and is anticipated to be worth around USD 656.16 billion by 2033, poised to grow at a CAGR of 14.48% from 2024 to 2033.

U.S. Home Healthcare Market Size 2024 to 2033

North America held the largest share of 50.59% share in 2023 in the home healthcare market. Over the past few years, the home healthcare market in North America has grown significantly, and this trend is anticipated to continue. This market includes a broad range of goods and services meant to help people receive medical attention and support in the comfort of their own homes. Skilled nursing care, physical therapy, occupational therapy, speech therapy, medical social services, and personal care support are all included in home healthcare services. Licensed healthcare providers or certified caregivers frequently offer these services. Patients have greater access to home healthcare services since they are frequently partially reimbursed by government healthcare programs like Medicare and Medicaid.

Home Healthcare Market Share, By Region, 2023 (%)

Asia Pacific also expected to grow at the fastest CAGR during forecast period. A number of factors, including an aging population, an increase in the frequency of chronic diseases, growing healthcare expenses, and technological improvements, have contributed to the tremendous rise that the home healthcare industry has been seeing in the Asia Pacific area. A vast array of medical and non-medical services, such as nursing care, physical therapy, occupational therapy, medical equipment rental, and home infusion therapy, are included in the category of home healthcare services. These services are given to patients in their homes. In the Asia-Pacific region, the prevalence of chronic illnesses like diabetes, heart disease, and respiratory conditions is rising. By giving patients in-home lifestyle assistance, medication management, and ongoing monitoring, home healthcare plays a critical role in managing chronic illnesses.

Home Healthcare Market Size in Asia Pacific 2023 to 2033

The Asia Pacific home healthcare market size surpassed USD 76.21 billion in 2023 and is projected to reach USD 347.4 billion by 2033.

Year Market Size (USD Billion)
2023 76.21
2024 87.80
2025 102.41
2026 120.77
2027 143.40
2028 166.19
2029 192.59
2030 223.2
2031 258.66
2032 299.76
2033 347.4

 

Home Healthcare Market Overview

Home healthcare refers to a variety of medical services that can be provided in the comfort of a patients’ own home to treat a sickness or accident. A patient's options for receiving home health care services are virtually endless. Care can range from nursing to specialized medical treatments, such as laboratory workups, depending on the individual patient's circumstance. The treatment plan and any treatments that the patient may require at home will be determined by the doctor. The duration of home healthcare can be short-term to long-term, depending on the health of the patient.

There are different types of home healthcare services available:

  • Personal care & companionship services usually include non-medical care apart from routine medical care such as senior care, assistive care, home health aide services. In such cases, the patient may or may not be suffering from any severe ailment(s).
  • Private duty nursing care is usually long-term nursing services for patients suffering from an injury, disability, or chronic illness.
  • Apart from these, home healthcare services can be short-term with a designated physician assigned to help a patient recover from an injury or illness.

Home healthcare may or may not be prescribed by the doctor. In cases where it is prescribed by the doctor, these services are generally covered by the insurance company.

Devices such as blood pressure monitoring devices, glucose monitoring devices, and other therapeutic & diagnostic devices are also classified under home healthcare. The scope of the home healthcare market covers devices as well as services.

The rising percentage of geriatric patients across the world especially in developed countries like Germany, France, Japan, and the United States is considered as one major driving factor which promotes the growth of the home healthcare market.

According to WHO, it is estimated that between 2015 to 2050, the population above 60 years will approximately double from 12% to 22% across the globe. As per the study, it is also observed that each elder patient suffered from at least two or more major chronic disorders which further fuels the growth of the market. In addition, the rising demand for advanced healthcare services followed by high acceptance from the end-users is considered a significant influence for the market growth.

The unhealthy aging of individuals will bring a huge opportunity for the healthcare services market. Recently, the rising penetrations of technology in the field of healthcare services followed by the delivery system are seen as a encouraging factor for the growth of the market. Rising investment in the upcoming technology followed by penetration of Artificial intelligence in healthcare is one of the major factors which will bring huge opportunities within the forecast period.

Developing countries with a mass population like India, China, Indonesia, Brazil, and others still need a good amount of time to develop and adapt themselves in the field of healthcare to become equivalent to developed countries. According to WHO, Counties like India lack the geriatric population and still need 20 more years to reach nearer to France.

Home Healthcare Market Scope

Report Highlights Details
Growth Rate from 2024 to 2033 CAGR of 14.81%
Market Size in 2023 USD 373.56 Billion
Market Size by 2033 USD 1,469.92 Billion
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Type, By Device, and By Services
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

 

Home Healthcare Market Dynamics

Market Drivers

The rising aging population & nuclear homes drive the need for home healthcare

Almost every country in the globe is seeing an increase in the number of older people and the proportion of them in their population. In 2019, the world's population of people aged 65 and up totaled 703 million. In 2050, the number of elderly people is expected to increase to 1.5 billion. The proportion of the world's population aged 65 and up went from 6% in 1990 to 9% in 2019. By 2050, that percentage is expected to climb to 16%, implying that one in every six individuals on the planet would be 65 or older.

Eastern and South-Eastern Asia, as well as Latin America and the Caribbean, have the fastest-aging populations. In Eastern and South-Eastern Asia, the percentage of people aged 65 and up about doubled from 6% in 1990 to 11% in 2019, and in Latin America and the Caribbean, the percentage of people aged 65 and up about doubled from 5% in 1990 to 9% in 2019. In four regions, Northern Africa and Western Asia, Central and Southern Asia, Latin America and the Caribbean, and Eastern and South-Eastern Asia, the proportion of older people are expected to treble between 2019 and 2050.

In the years 2015-2020, a 65-year-old person should expect to live a further 17 years on average over the world. That figure will have risen to 19 years by 2045-2050. In all countries, life expectancy at 65 is expected to rise between 2015 and 2020 and 2045-2050. Women presently outlive males by 4.8 years, but this disparity is likely to close over the next three decades.

The level of population aging appears to be dependent on age patterns of output and consumption, according to indicators that combine both demographic and economic data. The economic old-age dependency ratio, which combines measured levels of consumption and output by age, reveals that population aging has the largest influence on nations or areas with large numbers of older people and high levels of old-age consumption, such as Europe and Northern America, as well as Australia and New Zealand.

Increasing healthcare costs to drive the demand for affordable home health treatments

Healthcare costs are increasing all around the world due to advancements in technology, the complexity of procedures, multiple illnesses in patients, changing government policies, high insurance premiums, and limited coverages. For instance, healthcare costs have risen dramatically in the US over the past several decades. The American Medical Association (AMA) identified three key factors driving healthcare costs, viz., population growth, population aging, and rising prices. Besides these, disease prevalence or incidence of medical service utilization are other vital factors fueling healthcare costs as well.

As the population grows older and lives longer, healthcare becomes more expensive. As a result, rising service expenses, particularly inpatient hospital care, accounted for half of the growth in healthcare spending. Additionally, population increase (23%) and population aging are the two most important elements driving up such spending (12%).

Average yearly rates for family coverage for those with employer-provided healthcare increased by 37% from USD 15,545 in 2015 to USD 21,342 in 2020 for those with employer-provided healthcare. Meanwhile, from 2015 to 2020, average unsubsidized family premiums for the Affordable Care Act (ACA) increased by 97%, from USD 8,724 to USD 17,244.

Increased insurance prices are simply one part of the equation. Americans are spending more money out of pocket than they have in the past. High-deductible health plans (HDHPs), which impose out-of-pocket fees of up to USD 14,000 per family, have increased the cost of healthcare significantly. Employer payments to HDHPs help to offset the higher deductible, and according to one study from 2018, HDHP members paid 20% of their total premium, whereas PPO participants paid up to 27%.

Medicare and Medicaid, for example, have increased total demand for medical services, resulting in higher pricing. Increases in the cost of medical treatment have been directly correlated with increases in the incidence of chronic illnesses such as diabetes and heart disease, particularly among seniors.

Restraints:

Lack of Skilled Nursing Professionals

There has been a shortage of nursing staff which leads to limitation of growth of home healthcare market in developing countries like India. This shortage is primarily due to the insufficient number of qualified nurses available to meet the increasing demand for home-based healthcare services. According to an estimate India’s health workforce density is high than WHO recommended threshold of 44.5 skilled health workers per 10,000 people. However, despite the relatively high overall workforce density, there remains an imbalance in the distribution of healthcare professionals. Skilled nursing professionals are often concentrated in urban areas, leaving rural and remote regions underserved. In home healthcare, face to face interaction is low between doctor and nurse. Nurses often take on a more autonomous role, including conducting patient assessments and sharing their findings with the patient's primary care physician. This reduced direct supervision impairs the need for highly skilled and autonomous nurses in the home healthcare setting.

Moreover, In India, there is no coverage of insurances companies for home healthcare treatments for generic and chronic conditions which is hindrance to the growth of the home healthcare market in India. Insurance companies typically focus on post-hospitalization treatments, while many patients require ongoing care at home. This financial barrier can deter patients from seeking home-based healthcare services, limiting the market's expansion.

Opportunity:

The home healthcare sector has a significant opportunity for remote patient monitoring, or RPM. RPM uses technology to gather and send health information from patients' homes to medical professionals, which has several benefits. RPM makes it possible for patients to have continuous monitoring for chronic illnesses, which improves early problem detection and intervention and, in the end, improves patient outcomes and disease management. Additionally, it lowers ER visits and hospital readmissions, which saves a lot of money. In addition, RPM makes healthcare more accessible to underserved or remote locations, supports individualized treatment based on real-time data, promotes patient involvement, and ultimately turns out to be cost-effective. In order to effectively benefit of this potential, home health care providers require technological and personnel training investments, work with device manufacturers, and guarantee compliance with data privacy laws. Therefore, Adopting RPM leads several opportunities for market growth and development in healthcare delivery by enabling providers to provide better patient care, lower costs, and increase accessibility to healthcare services.

Type Insights

The services segment held the largest share of 84.07% in 2023 in the home healthcare market. A variety of services that are offered to patients in their homes to meet their medical needs are included in the home healthcare market. This market's service sector usually consists of a range of healthcare services that are provided by qualified experts to patients in their homes. Assistance with activities of daily living (ADLs) like clothing, grooming, meal preparation, and light cleaning is given by home health aides (HHAs) or personal care assistants. This entails the provision of expert nursing care by licensed practical nurses (LPNs) or registered nurses (RNs) in order to monitor vital signs, manage complicated medical problems, give medicine, treat wounds, and instruct patients and their families in health condition management.

Home Healthcare Market Share, By Type, 2023 (%)

Rehabilitative treatments are offered by physical therapists (PTs) to patients who are recuperating from surgery, injuries, or illnesses. By using exercises, manual treatment, and other methods, they assist patients in achieving greater strength, endurance, mobility, and balance. Occupational therapists (OTs) assist patients in regaining or acquiring the skills necessary for doing everyday tasks including getting dressed, cooking, and using the restroom.

Device Insights

The Home Mobility Assist Devices segment held the largest share of 40.26% in 2023 in the home healthcare market. When it comes to helping people who have mobility issues as a result of age, accident, or disability, home mobility assist devices are essential to the home healthcare industry. These technologies give users the ability to carry out daily tasks and move around their houses safely, which improves independence and quality of life. People with restricted or no walking abilities can move around with the use of manual and electric wheelchairs. Those who can walk but need assistance can benefit from the stability and support provided by these devices. Canes aid in stability and balance, especially for people who require little assistance. With the use of these assistive gadgets, people with mobility impairments can safely climb stairs and descend hills.

Home Healthcare Market, By Device, 2020-2023 (USD Billion)

By Device 2020 2021 2022 2023
Diagnostic & Monitoring Devices 12,638.8 14,368.0 16,403.2 18,794.6
Therapeutic Devices 12,518.5 13,778.2 15,186.2 16,761.8
Home Mobility Assist Devices 19,053.7 20,602.0 22,238.5 23,965.3

 

The aging population and the rise in the number of disabled individuals are driving up demand for home mobility assistance products. Modern technological innovations like ergonomic designs and lightweight materials are making these gadgets more comfortable and easier to use. As more people look for ways to receive care in the comfort and safety of their own homes, the COVID-19 epidemic has also hastened the development of home healthcare solutions, including mobility aid devices. Sensors and networking capabilities are being added by manufacturers to mobility devices in order to improve user safety and offer remote monitoring. Personalized solutions that address the unique requirements and preferences of individual consumers are becoming more and more popular.

Service Insights

The rehabilitation held the largest share of 44.12% in 2023 in the home healthcare market. In home healthcare, the term "rehabilitation" refers to a variety of therapeutic approaches intended to improve or restore a patient's functional, cognitive, or physical capacities after a disease, surgery, or injury. The need for rehabilitation services in home healthcare is expanding due to an aging population and an increase in the prevalence of chronic illnesses and disabilities. Rehabilitative services allow patients to reach their recovery objectives while retaining their independence, as most patients choose to receive care in the comfort of their own homes. A broad range of rehabilitation treatments, including physical therapy, occupational therapy, speech therapy, and cognitive rehabilitation, are being offered by home healthcare firms.

Home Healthcare Market, By Service, 2020-2023 (USD Billion)

By Services 2020 2021 2022 2023
Rehabilitation 109,827.8 118,814.4 128,382.9 138,558.7
Telehealth 16,600.1 25,123.7 35,992.5 50,859.5
Respiratory Therapy 33,077.7 37,868.8 41,270.1 45,447.4
Infusion Therapy 14,687.9 17,200.3 19,171.6 21,589.3
Unskilled Homecare 46,466.1 51,485.0 54,213.8 57,579.5

 

Technological innovations like wearables, telemedicine platforms, and remote monitoring systems are making it easier to provide rehabilitative services in home healthcare. Through the use of virtual sessions, remote patient monitoring, and plan modifications, tele-rehabilitation improves patient outcomes and increases access to therapy. A multidisciplinary team of medical specialists, including physical therapists, occupational therapists, speech-language pathologists, nurses, and social workers, are frequently involved in rehabilitation in home healthcare. Throughout the rehabilitation process, therapists collaborate closely with patients and their families to create individualized treatment plans that encourage motivation, empowerment, and involvement. When compared to inpatient or outpatient care, home-based rehabilitation can be more affordable since it saves money on hospital stays, transportation costs, and facility-based services.

Some of the significant players:

Manufacturers: -

  • McKesson Medical-Surgical Inc.
  • Fresenius Medical Care
  • Becton, Dickinson And Company
  • Arkray, Inc.
  • Medline Industries, Inc.
  • 3M Healthcare
  • Baxter International Inc.
  • Medtronic PLC
  • Braun Melsungen AG
  • ConvaTec Group PLC
  • Molnlycke Health Care
  • Acelity L.P.
  • Hollister Inc.
  • Others

 Service Providers: -

  • Sunrise Carlisle, LP
  • Extendicare, Inc.
  • Brookdale Senior Living, Inc.
  • Home Health Services Ltd.
  • Care UK Limited
  • Kindred Healthcare, Inc.
  • Genesis Healthcare Corp.
  • Sompo Holdings, Inc.
  • Home Instead Senior Care, Inc.
  • Others

Segments Covered in the Report

By Type

  • Device
  • Services

By Device

  • Diagnostic & Monitoring Devices
  • Therapeutic Devices
  • Home Mobility Assist Devices

By Services

  • Rehabilitation
  • Telehealth
  • Respiratory Therapy
  • Infusion Therapy
  • Unskilled Homecare

By Regional Outlook

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East and Africa
    • GCC
    • North Africa
    • South Africa
    • Rest of MEA

Frequently Asked Questions

The global home healthcare market size was reached at USD 373.56 billion in 2023 and is expected to be worth around USD 1,469.92 billion by 2033.

Some of the players of home healthcare market include McKesson Medical-Surgical Inc., Fresenius Medical Care, Medline Industries, Inc., 3M Healthcare, Baxter International Inc., Medtronic PLC, B. Braun Melsungen AG, Molnlycke Health Care F. Hoffmann-La Roche AG, Arkray, Inc., Becton, Dickinson And Company, Acelity L.P., Hollister Inc., ConvaTec Group PLC, and Others.

North America seems to dominate the global home healthcare market.

The global home healthcare market is growing with a CAGR of 14.81% from 2024 to 2033.

The term home healthcare represents a wide number of community-based solutions to assist individuals suffering from acute to chronic disorders such as blood pressure, respiratory disorders, kidney, hip fracture, cerebral palsy, heart disorders, and others.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Home Healthcare Market 

5.1. COVID-19 Landscape: Home Healthcare Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Home Healthcare Market, By Type

8.1. Home Healthcare Market, by Type, 2024-2033

8.1.1. Device

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Home Healthcare Market, By Device

9.1. Home Healthcare Market, by Device, 2024-2033

9.1.1. Diagnostic & Monitoring Devices

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Therapeutic Devices

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Home Mobility Assist Devices

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Home Healthcare Market, By Services 

10.1. Home Healthcare Market, by Services, 2024-2033

10.1.1. Rehabilitation

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Telehealth

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Respiratory Therapy

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Infusion Therapy

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Unskilled Homecare

10.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Home Healthcare Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2021-2033)

11.1.2. Market Revenue and Forecast, by Device (2021-2033)

11.1.3. Market Revenue and Forecast, by Services (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Device (2021-2033)

11.1.4.3. Market Revenue and Forecast, by Services (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Device (2021-2033)

11.1.5.3. Market Revenue and Forecast, by Services (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.2. Market Revenue and Forecast, by Device (2021-2033)

11.2.3. Market Revenue and Forecast, by Services (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Device (2021-2033)

11.2.4.3. Market Revenue and Forecast, by Services (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Device (2021-2033)

11.2.5.3. Market Revenue and Forecast, by Services (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Device (2021-2033)

11.2.6.3. Market Revenue and Forecast, by Services (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Device (2021-2033)

11.2.7.3. Market Revenue and Forecast, by Services (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.2. Market Revenue and Forecast, by Device (2021-2033)

11.3.3. Market Revenue and Forecast, by Services (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Device (2021-2033)

11.3.4.3. Market Revenue and Forecast, by Services (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Device (2021-2033)

11.3.5.3. Market Revenue and Forecast, by Services (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Device (2021-2033)

11.3.6.3. Market Revenue and Forecast, by Services (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Device (2021-2033)

11.3.7.3. Market Revenue and Forecast, by Services (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.2. Market Revenue and Forecast, by Device (2021-2033)

11.4.3. Market Revenue and Forecast, by Services (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Device (2021-2033)

11.4.4.3. Market Revenue and Forecast, by Services (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Device (2021-2033)

11.4.5.3. Market Revenue and Forecast, by Services (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Device (2021-2033)

11.4.6.3. Market Revenue and Forecast, by Services (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Device (2021-2033)

11.4.7.3. Market Revenue and Forecast, by Services (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.5.2. Market Revenue and Forecast, by Device (2021-2033)

11.5.3. Market Revenue and Forecast, by Services (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Device (2021-2033)

11.5.4.3. Market Revenue and Forecast, by Services (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Device (2021-2033)

11.5.5.3. Market Revenue and Forecast, by Services (2021-2033)

Chapter 12. Company Profiles

12.1. McKesson Medical-Surgical Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Fresenius Medical Care

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Becton, Dickinson And Company

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Arkray, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Medline Industries, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. 3M Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Baxter International Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Medtronic PLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Braun Melsungen AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. ConvaTec Group PLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Molnlycke Health Care

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

12.12. Acelity L.P.

12.12.1. Company Overview

12.12.2. Product Offerings

12.12.3. Financial Performance

12.12.4. Recent Initiatives

12.13. Hollister Inc.

12.13.1. Company Overview

12.13.2. Product Offerings

12.13.3. Financial Performance

12.13.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client